Fatal asymmetric interstitial lung disease after erlotinib for lung cancer

Respiration

Volumn 84, Issue 5, 2012, Pages 431-435

  Ren, Shaohua ^a   Li, Yuan ^a   Li, Weiwen ^a   Zhao, Zhongwei ^a   Jin, Chunxian ^a   Zhang, Dengke ^a  

^a LISHUI CENTRAL HOSPITAL   (China)

Author keywords

Erlotinib; Interstitial lung disease; Lung cancer; Selective bronchial artery embolization

Indexed keywords

ERLOTINIB; METHYLPREDNISOLONE;

AGED; ARTERIAL GAS; ARTICLE; ARTIFICIAL EMBOLISM; ATELECTASIS; BRONCHIAL ARTERY EMBOLIZATION; CASE REPORT; COUGHING; DRUG INDUCED DISEASE; FEMALE; HEMOPTYSIS; HUMAN; HUMAN TISSUE; INTERSTITIAL LUNG DISEASE; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

ADENOCARCINOMA; AGED; FATAL OUTCOME; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; PROTEIN KINASE INHIBITORS; QUINAZOLINES;

EID: 84867843511     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000339508     Document Type: Article

References (15)

1. Camus P, Fanton A, Bonniaud Ph, et al: Interstitial lung disease induced by drugs and radiation. Respiration 2004; 71: 301-326.
2. Camus P, Kudoh S, Ebina M: Interstitial lung disease associated with drug therapy. Br J Cancer 2004; 91:S18-S23.
3. Zhou C, Wu YL, Chen G, et al: Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase III study. Lancet Oncol 2011; 12: 735-742.
4. Peerzada MM, Spiro TP, Daw HA: Pulmonary toxicities of tyrosine kinase inhibitors. Clin Adv Hematol Oncol 2011; 9: 824-836.
5. Takano T, Ohe Y, Kusumoto M, et al: Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinib. Lung Cancer 2004; 45: 93-104.
6. Padley SP, Jordan SJ, Goldstraw P, et al: Asymmetric ARDS following pulmonary resection: CT findings - initial observations. Radiology 2002; 223: 468-473.
7. Kondoh Y, Taniguchi H, Kitaichi M, et al: Acute exacerbation of interstitial pneumonia following surgical lung biopsy. Respir Med 2006; 100: 1753-1759.
8. Pashinsky YY, Jaffin BW, Litle VR, et al: Gastroesophageal reflux disease and idiopathic pulmonary fibrosis. Mt Sinai J Med 2009; 76: 24-29.
9. Tcherakian C, Cottin V, Brillet PY, et al: Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease. Thorax 2011; 66: 226-231.
10. Chong S, Kim TS, Chung MP, et al: Unilateral usual interstitial pneumonia associated with sarcoma of the pulmonary artery. AJR Am J Roentgenol 2007; 189:W221-W223.
11. Ryu DS, Ahn JH, Choi SJ, et al: Congenital absence of the right interlobar pulmonary artery: HRCT findings. J Thorac Imaging 2008; 23: 292-294.
12. Traber DL, Hawkins HK, Enkhbaatarm P, et al: The role of the bronchial circulation in the acute lung injury resulting from burn and smoke inhalation. Pulm Pharmacol Ther 2007; 20: 163-166.
13. Pump KK: Distribution of bronchial arteries in the human lung. Chest 1972; 62: 447-451.
14. Kotoulas C, Melachrinou M, Konstantinou GN, et al: Bronchial arteries: an arteriosclerosis- resistant circulation. Respiration 2010; 79: 333-339.
15. Ter Heine R, van den Bosch RT, Schaefer- Prokop CM, et al: Fatal interstitial lung disease associated with high erlotinib and metabolite levels. A case report and a review of the literature. Lung Cancer 2012; 75: 391-397.